SCHEMBL890891

SCHEMBL890891

Cc1cc(CC(C)C)c[nH]1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HMBS P08397 1/20 0.40
GABRA1 P14867 1/20 0.36
GABRB2 P47870 1/20 0.36
MEN1 O00255 3/20 0.35
KMT2A Q03164 3/20 0.35
POLB P06746 2/20 0.35
MAPT P10636 2/20 0.35
DAO P14920 1/20 0.32
NOTUM Q6P988 1/20 0.32
PTGS2 P35354 4/20 0.31
PTGS1 P23219 3/20 0.31
LMNA P02545 3/20 0.31
CYP2C9 P11712 3/20 0.31
ESR1 P03372 3/20 0.31
AKR1C3 P42330 2/20 0.31
CXCR1 P25024 2/20 0.31
CXCR2 P25025 2/20 0.31
ALOX5 P09917 2/20 0.31
NFKB1 P19838 2/20 0.31
HTR2A P28223 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12394766 0.79 DAO (0.39) GABRA1GABRB2MEN1KMT2APOLB
SCHEMBL15885949 0.77 XDH (0.35) GABRA1GABRB2MEN1KMT2APOLB
SCHEMBL19220573 0.77 GABRA1 (0.34) GABRA1GABRB2MEN1KMT2APOLB
SCHEMBL24664734 0.77 DAO (0.39) MEN1KMT2APOLBMAPTDAO
SCHEMBL891014 0.76 GABRA1 (0.33) GABRA1GABRB2MEN1KMT2APOLB
SCHEMBL28005950 0.73 MEN1 (0.34) GABRA1GABRB2MEN1KMT2APOLB
SCHEMBL5804646 0.72
SCHEMBL22861797 0.71 MEN1 (0.40) GABRA1GABRB2MEN1KMT2APOLB
SCHEMBL23863960 0.71 DAO (0.54) GABRA1GABRB2DAO
SCHEMBL23241465 0.70

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 66 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8362278-B2 Methods for the conversion of a substituted furan to a substituted pyrrole CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) 2013-01-29 US claimed
US-20120083609-A1 METHODS FOR THE CONVERSION OF A SUBSTITUTED FURAN TO A SUBSTITUTED PYRROLE CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) 2012-04-05 US claimed
CN-122070352-A Sustainable aviation fuel produced from normal alpha olefin byproducts and method thereof 切弗朗菲利浦化学公司 2026-05-19 CN disclosed
US-12618016-B2 Methods for producing aviation fuels CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) 2026-05-05 US disclosed
US-20260103649-A1 SUSTAINABLE AVIATION FUEL FROM NORMAL ALPHA OLEFIN BYPRODUCTS AND PROCESS FOR SAME CHEVRON PHILLIPS CHEMICAL CO LP (US) 2026-04-16 US disclosed
WO-2026043730-A1 METHODS FOR PRODUCING AVIATION FUELS CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) 2026-02-26 WO disclosed
US-20260049256-A1 METHODS FOR PRODUCING AVIATION FUELS CHEVRON PHILLIPS CHEMICAL COMPANY LP 2026-02-19 US disclosed
US-12540287-B2 Sustainable aviation fuel from normal alpha olefin byproducts and process for same CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) 2026-02-03 US disclosed
US-12528999-B2 Sustainable jet fuel and process CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) 2026-01-20 US disclosed
WO-2025054258-A1 SUSTAINABLE AVIATION FUEL FROM NORMAL ALPHA OLEFIN BYPRODUCTS AND PROCESS FOR SAME CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) 2025-03-13 WO disclosed
WO-2025054252-A1 SUSTAINABLE JET FUEL AND PROCESS CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) 2025-03-13 WO disclosed
US-8450511-B1 Anhydrous chromium(III) halide complex preparation CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) 2013-05-28 US disclosed
US-8420810-B2 Bicyclic heterocyclic compound Ono Pharmaceutical, Co., Ltd. (JP) 2013-04-16 US disclosed
EP-2563511-A1 OLIGOMERIZATION CATALYST SYSTEM AND PROCESS FOR OLIGOMERIZING OLEFINS Chevron Phillips Chemical Company LP (US) 2013-03-06 EP disclosed
US-8362278-B2 Methods for the conversion of a substituted furan to a substituted pyrrole CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) 2013-01-29 US disclosed
US-20120083609-A1 METHODS FOR THE CONVERSION OF A SUBSTITUTED FURAN TO A SUBSTITUTED PYRROLE CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) 2012-04-05 US disclosed
WO-2011137027-A1 OLIGOMERIZATION CATALYST SYSTEM AND PROCESS FOR OLIGOMERIZING OLEFINS CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) 2011-11-03 WO disclosed
US-20100274065-A1 OLIGOMERIZATION CATALYST SYSTEM AND PROCESS FOR OLIGOMERIZING OLEFINS CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) 2010-10-28 US disclosed
US-20100137318-A1 BICYCLIC HETEROCYCLIC COMPOUND ONO PHARMACEUTICAL CO., LTD. (JP) 2010-06-03 US disclosed
EP-2154139-A1 BICYCLIC HETEROCYCLIC COMPOUND ONO Pharmaceutical Co., Ltd. (JP) 2010-02-17 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12618016-B2 Methods for producing aviation fuels CYP4F8, CYP8B1, CYP2E1 HMBS 976/4885GABRA1 3274/4885GABRB2 2625/4885
US-20120083609-A1 METHODS FOR THE CONVERSION OF A SUBSTITUTED FURAN TO A SUBSTITUTED PYRROLE PAH, CPS1, ASNS HMBS 50/4885GABRA1 3232/4885GABRB2 2608/4885
US-20260103649-A1 SUSTAINABLE AVIATION FUEL FROM NORMAL ALPHA OLEFIN BYPRODUCTS AND PROCESS FOR SAME YAP1, CYP4F8, SCD HMBS 2151/4885GABRA1 968/4885GABRB2 1064/4885
US-12528999-B2 Sustainable jet fuel and process CYP2E1, ADH1C, PCCA HMBS 1605/4885GABRA1 841/4885GABRB2 743/4885
US-20260049256-A1 METHODS FOR PRODUCING AVIATION FUELS CYP4F8, CPT1A, CBR1 HMBS 490/4885GABRA1 3112/4885GABRB2 2845/4885
US-12540287-B2 Sustainable aviation fuel from normal alpha olefin byproducts and process for same ADH1A, ADH1C, YAP1 HMBS 1540/4885GABRA1 1162/4885GABRB2 1127/4885
US-20100274065-A1 OLIGOMERIZATION CATALYST SYSTEM AND PROCESS FOR OLIGOMERIZING OLEFINS DHPS, PPOX, HPD HMBS 8/4885GABRA1 4178/4885GABRB2 4070/4885
US-20100137318-A1 BICYCLIC HETEROCYCLIC COMPOUND CRH, CRHR1, NR3C2 HMBS 2665/4885GABRA1 480/4885GABRB2 424/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.